FL S0954

Creates section 385.301, Florida Statutes, establishing a regulatory framework for investigational stem cell treatments using adult stem cells in FDA-approved clinical trials for patients with severe chronic diseases or terminal illnesses.

Requires the Department of Health to adopt rules by January 1, 2020, designating qualifying medical conditions and establishing institutional review board requirements for overseeing stem cell treatments.

Mandates that eligible patients sign written informed consent before receiving treatment, which must be administered by a licensed physician certified by an institutional review board and provided at a hospital, ambulatory surgical center, or accredited medical school.

Prohibits licensing boards from revoking or suspending a physician's license based solely on recommending investigational stem cell treatments to eligible patients, and prohibits state entities from interfering with patient access to authorized treatments.

Amends section 873.01 to clarify that stem cells are included in the prohibition on purchasing or selling human organs and tissue, making such violations felonies of the second degree.